"Aplikacija “ECHOS³” je vlasništvo Ehokardiografskog udruženja Srbije (u daljem tekstu ECHOS), razvijena od strane Nenad Biočanin PR LLAMA SOLUTIONS.

Svrha aplikacije je edukativnog karaktera i služi kao pomoć lekarima na primarnom nivou pri  pravovremenom prepoznavanju bolesnika pod rizikom za razvoj SS ili ispoljenom a nedijagnostikovanom SS.

Lista navedenih lekova u sekciji Lekovi je preuzeta sa stranice ALIMSa na dan 14.11.2022. ECHOS i Nenad Biočanin PR LLAMA SOLUTIONS ne snose odgovornost za eventualnu neažurnost podataka.

Korišćenjem aplikacije “ECHOS³” ne prikupaju se nikakvi podaci od strane korisnika.”

Izvori:

1. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-726.

2. Pieske B, Tschöpe C, de Boer RA, et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019;40(40):3297-317.

3. Faden G, Faganello G, De Feo S, et al. The increasing detection of asymptomatic left ventricular dysfunction in patients with type 2 diabetes mellitus without overt cardiac disease: data from the SHORTWAVE study. Diabetes Res Clin Pract. 2013;101(3):309-16.

4. Nayor M, Larson MG, Wang N, et al. The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction. Eur J Heart Fail. 2017;19(5):615-23.

5. Butler J, Kalogeropoulos A, Georgiopoulou V, et al. Incident heart failure prediction in the elderly: the health ABC heart failure score. Circ Heart Fail. 2008;1(2):125-33.

6. Kalogeropoulos A, Psaty BM, Vasan RS, et al. Validation of the health ABC heart failure model for incident heart failure risk prediction: the Cardiovascular Health Study. Circ Heart Fail. 2010;3(4):495-502."